Jiang Y, Qi S, Zhang R, Zhao R, Fu Y, Fang Y
Front Oncol. 2025; 14:1483521.
PMID: 39935848
PMC: 11810725.
DOI: 10.3389/fonc.2024.1483521.
Zhang H, Xu Y, Han H, Ye X, Cheng L, Shen Y
Cancer Control. 2024; 31:10732748241287904.
PMID: 39323031
PMC: 11440566.
DOI: 10.1177/10732748241287904.
Sun L, Shao W, Lin Z, Lin J, Zhao F, Yu J
Discov Oncol. 2024; 15(1):409.
PMID: 39235657
PMC: 11377405.
DOI: 10.1007/s12672-024-01286-5.
Jia Y, Yang L, Zhu Y, Ma C
Am J Transl Res. 2023; 15(2):982-994.
PMID: 36915794
PMC: 10006774.
Miyashita R, Nishiyama A, Qin W, Chiba Y, Kori S, Kato N
Elife. 2023; 12.
PMID: 36734974
PMC: 9943068.
DOI: 10.7554/eLife.79013.
Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors.
Liu X, Cheng C, Cai Y, Gu Y, Wu Y, Chen K
Int J Oncol. 2022; 60(6).
PMID: 35425993
PMC: 9084552.
DOI: 10.3892/ijo.2022.5356.
PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis.
Liu X, Cai Y, Cheng C, Gu Y, Hu X, Chen K
Cell Death Dis. 2022; 13(2):178.
PMID: 35210406
PMC: 8873510.
DOI: 10.1038/s41419-022-04635-w.
Increased gene expression associated with poor prognosis in breast cancer.
Liu J, He Y, Li C, Zhou R, Yuan Q, Hou J
Transl Cancer Res. 2022; 10(9):4009-4019.
PMID: 35116699
PMC: 8797655.
DOI: 10.21037/tcr-20-3064.
Overexpression of 15-Hydroxyprostaglandin Dehydrogenase Inhibits A549 Lung Adenocarcinoma Cell Growth via Inducing Cell Cycle Arrest and Inhibiting Epithelial-Mesenchymal Transition.
Wang W, Yang C, Deng H
Cancer Manag Res. 2021; 13:8887-8900.
PMID: 34876851
PMC: 8643138.
DOI: 10.2147/CMAR.S331222.
Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors.
Liu L, Liao J, Zhu F
World J Gastrointest Oncol. 2021; 13(10):1425-1439.
PMID: 34721775
PMC: 8529917.
DOI: 10.4251/wjgo.v13.i10.1425.
PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues.
Tantiwetrueangdet A, Panvichian R, Sornmayura P, Leelaudomlipi S, Macoska J
BMC Cancer. 2021; 21(1):295.
PMID: 33743635
PMC: 7981960.
DOI: 10.1186/s12885-021-07994-3.
Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38/snail1 pathway in glioma.
Liu J, Gao L, Liao J, Yang J, Yuan F, Chen Q
Ann Transl Med. 2021; 9(3):260.
PMID: 33708887
PMC: 7940917.
DOI: 10.21037/atm-20-3219.
Different anaesthesia methods affect the development of hepatoblastoma after platelet activation.
Fei G, Cao M, Ge C, Xie Y
Int J Exp Pathol. 2021; 102(1):51-56.
PMID: 33410572
PMC: 7839956.
DOI: 10.1111/iep.12378.
MicroRNA‑216a‑5p suppresses esophageal squamous cell carcinoma progression by targeting KIAA0101.
Sun T, An Q, Yan R, Li K, Zhu K, Dang C
Oncol Rep. 2020; 44(5):1971-1984.
PMID: 32901882
PMC: 7551273.
DOI: 10.3892/or.2020.7751.
Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis.
Xu W, Wang X, Wu X, Yu S, Xiong J, Sang X
Aging (Albany NY). 2020; 12(16):16420-16436.
PMID: 32855364
PMC: 7485719.
DOI: 10.18632/aging.103704.
Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma.
Singh A, Gu J, Zhang Q, Torka P, Sundaram S, Mavis C
Cancer Metab. 2020; 8:10.
PMID: 32647571
PMC: 7336499.
DOI: 10.1186/s40170-020-00213-w.
Human PCNA Structure, Function and Interactions.
Gonzalez-Magana A, Blanco F
Biomolecules. 2020; 10(4).
PMID: 32276417
PMC: 7225939.
DOI: 10.3390/biom10040570.
Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
Li L, Zhao J, Zhou L, Chen J, Ma Y, Yu Y
Respir Res. 2019; 20(1):163.
PMID: 31331325
PMC: 6647111.
DOI: 10.1186/s12931-019-1102-2.
Robust network-based regularization and variable selection for high-dimensional genomic data in cancer prognosis.
Ren J, Du Y, Li S, Ma S, Jiang Y, Wu C
Genet Epidemiol. 2019; 43(3):276-291.
PMID: 30746793
PMC: 6446588.
DOI: 10.1002/gepi.22194.
2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.
Nagaprashantha L, Singhal J, Chikara S, Gugiu G, Horne D, Awasthi S
J Proteomics. 2018; 192:233-245.
PMID: 30248461
PMC: 8817450.
DOI: 10.1016/j.jprot.2018.09.005.